产品说明书

HS-1371

Print
Chemical Structure| 2158197-70-5 同义名 : -
CAS号 : 2158197-70-5
货号 : A982329
分子式 : C24H24N4O
纯度 : 99%+
分子量 : 384.474
MDL号 : MFCD31813738
存储条件:

粉末 Keep in dark place,Inert atmosphere,2-8°C

液体 -20°C:3-6个月-80°C:12个月

溶解度 :

DMSO: 16 mg/mL(41.62 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO

动物实验配方:
生物活性
描述 Necroptosis is a type of programmed cell death that usually occurs under apoptosis-deficient conditions. Receptor-interacting protein kinase-3 (RIP3) is a central player in necroptosis, and its kinase activity is essential for downstream necroptotic signaling events. HS-1371 is a potent and ATP-competitive RIP3 inhibitor with an IC50 value of 20.8 nM. HS-1371 showed an inhibitory effect on S227 auto-phosphorylation of RIP3 at the basal level in a dose-dependent manner, indicating that HS-1371 can be used as potential preventive agent in RIP3-mediated necroptotic cell death. HT-29 cells were treated with TRAIL (stimuli leading to necroptosis) plus Smac mimetic and zVAD to induce TRAIL-mediated necroptosis; HS-1371 decreased TRAIL-induced S227 phosphorylation of RIP3 and RIP3-mediated phosphorylation of MLKL in a dose-dependent manner indicating that RIP3-mediated necroptosis could be inhibited by HS-1371. In HeLa cells that lack endogenous RIP3 expression, the ectopic expression of RIP3 resulted in basal activation of RIP3 phosphorylation; this activity was decreased by HS-1371 in a dose-dependent manner. RIP3 phosphorylation was markedly increased by TSZ treatment, but pretreatment of HS-1371 effectively blocked RIP3 phosphorylation and MLKL phosphorylation. TNF-mediated necroptosis was induced and then HS-1371 was applied 1 or 2 h later. Low concentrations of HS-1371 showed a partial inhibitory effect on RIP3 phosphorylation in both pre-treatment and post-treatment, but 5 μM HS-1371 completely inhibited RIP3 phosphorylation and TNF-induced cell death[1].
作用机制 The ability of HS-1371 to establish hydrogen bonds with the backbone groups in the hinge region of RIP3 is necessary for its tight binding in the ATP-binding site of RIP3[1].
实验方案
1mg 5mg 10mg

1 mM

5 mM

10 mM

2.60mL

0.52mL

0.26mL

13.00mL

2.60mL

1.30mL

26.01mL

5.20mL

2.60mL

参考文献

[1]Park HH, Park SY, Mah S, et al. HS-1371, a novel kinase inhibitor of RIP3-mediated necroptosis. Exp Mol Med. 2018;50(9):125. Published 2018 Sep 20